Vimarsana
Biggest News Aggregation in the World

Page 26 - Translational Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Translational Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Translational Sciences Today - Breaking & Trending Today

Exploring the link between red meat intake and inflammation - Vimarsana News

Exploring the link between red meat intake and inflammation

Inflammation is a risk factor for many chronic diseases, including cardiovascular disease (CVD), and the impact of diet on inflammation is an area of growing scientific interest.

3 Stocks Cathie Wood Is Buying That Should Be on Your List Too - Vimarsana News

3 Stocks Cathie Wood Is Buying That Should Be on Your List Too

The three companies are positioned to benefit from red-hot trends.

Source: fool.com
Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update - Vimarsana News

Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update

LONDON, Oct. 23, 2023 -- Mereo BioPharma Group plc , a clinical-stage biopharmaceutical company focused on rare diseases, today provided an update on recent program developments and third quarter...

65 Million People Suffer From Long Covid. Our Experts Say New Vaccines Are The Best Defense - Vimarsana News

65 Million People Suffer From Long Covid. Our Experts Say New Vaccines Are The Best Defense

Updated Covid vaccines based on Nobel prize-winning mRNA technology provide added protection — especially important when Covid-19, flu and RSV infections spike.

Source: forbes.com
Scholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual Meeting - Vimarsana News

Scholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual Meeting

Poster presentations to include safety, efficacy, and biomarker data from Part A and B of the DRAGON trial in patients with advanced solid tumors treated with SRK-181 ...